Alexander Fitzalan Howard, Zenah Shuhaiber, Tim Lewis
Structure
Europe
AIC sector
Europe
Domicile
United Kingdom
Base currency
GBP
Launched
1929-03-15
Latest factsheet
2026-05-31
Snapshot date
2025-08-31
Price & NAV
Share price
135.60p
NAV / share
141.77p2026-10-12
Premium / discount
-4.35%
Key facts
Fund size
£660m
OCF
0.64%
Performance fee
—
Gearing
4.90%
Dividend yield
3.40%
Performance
cumulativevs MSCI Europe ex UK (total return) (£)
Period
Return
Benchmark
Vs
1m
6.0%
3.8%
+2.2pp
3m
-3.6%
-2.1%
-1.5pp
ytd
6.0%
6.5%
-0.5pp
1y
25.9%
22.2%
+3.7pp
annualised
Top holdings (10)
#
Holding
Sector
Country
Weight
1
ASML
Semiconductors & Semiconductor Equipment
—
6.0%
2
Roche
Pharmaceuticals Biotechnology & Life Sci
—
3.5%
3
Novartis
Pharmaceuticals Biotechnology & Life Sci
—
3.0%
4
Nestle
Food Beverage & Tobacco
—
3.0%
Sector breakdown
Capital Goods
17.4%
Others
16.8%
Banks
13.3%
Pharmaceuticals Biotechnology & Life Sci
9.5%
Semiconductors & Semiconductor Equipment
8.4%
Insurance
6.8%
Financial Services
Portfolio metrics
Portfolio yield
3.04%
Unlisted holdings
—
Cash & equivalents
2.58%
Total assets
£590.2m
Revenue reserves
£0
Gearing & leverage
Net gearing
5.60%
Fund objective
The Company aims to provide capital growth and a rising share price over the longer term from Continental European investments by out-performance of the benchmark by taking carefully controlled risks through an investment method that is clearly communicated to shareholders. The Company has the ability to use borrowing to gear the portfolio within the range of 10% net cash to 20% geared in normal market conditions. Gearing may magnify gains or losses experienced by the Company. The Company pays four dividends per financial year in July, October, January and March and calculated as 4% per annum based on the NAV as at close of business on 31st March of the preceding financial year.
Alexander Fitzalan Howard, Zenah Shuhaiber, Tim Lewis
Structure
Europe
AIC sector
Europe
Domicile
United Kingdom
Base currency
GBP
Launched
1929-03-15
Latest factsheet
2026-05-31
Snapshot date
2025-08-31
Price & NAV
Share price
135.60p
NAV / share
141.77p2026-10-12
Premium / discount
-4.35%
Key facts
Fund size
£660m
OCF
0.64%
Performance fee
—
Gearing
4.90%
Dividend yield
3.40%
Performance
cumulativevs MSCI Europe ex UK (total return) (£)
Period
Return
Benchmark
Vs
1m
6.0%
3.8%
+2.2pp
3m
-3.6%
-2.1%
-1.5pp
ytd
6.0%
6.5%
-0.5pp
1y
25.9%
22.2%
+3.7pp
annualised
Top holdings (10)
#
Holding
Sector
Country
Weight
1
ASML
Semiconductors & Semiconductor Equipment
—
6.0%
2
Roche
Pharmaceuticals Biotechnology & Life Sci
—
3.5%
3
Novartis
Pharmaceuticals Biotechnology & Life Sci
—
3.0%
4
Nestle
Food Beverage & Tobacco
—
3.0%
Sector breakdown
Capital Goods
17.4%
Others
16.8%
Banks
13.3%
Pharmaceuticals Biotechnology & Life Sci
9.5%
Semiconductors & Semiconductor Equipment
8.4%
Insurance
6.8%
Financial Services
Portfolio metrics
Portfolio yield
3.04%
Unlisted holdings
—
Cash & equivalents
2.58%
Total assets
£590.2m
Revenue reserves
£0
Gearing & leverage
Net gearing
5.60%
Fund objective
The Company aims to provide capital growth and a rising share price over the longer term from Continental European investments by out-performance of the benchmark by taking carefully controlled risks through an investment method that is clearly communicated to shareholders. The Company has the ability to use borrowing to gear the portfolio within the range of 10% net cash to 20% geared in normal market conditions. Gearing may magnify gains or losses experienced by the Company. The Company pays four dividends per financial year in July, October, January and March and calculated as 4% per annum based on the NAV as at close of business on 31st March of the preceding financial year.